Product Reports Resources Pricing Login Book a demo

Intelligencia

Biotech & Life Sciences · New York City, United States · Founded 2017

Applying machine learning in drug development MoreLess

Intelligencia AI is a health tech company that leverages artificial intelligence to revolutionize drug development in the pharmaceutical industry. By providing AI-driven insights, the company helps enhance clinical development, mitigate risks, and enable confident business decisions. Intelligencia AI serves many of the top global pharmaceutical companies, offering solutions built with comprehensive and precise data. Their services include real-time tracking of clinical programs, expert data curation, and quality control by biomedical professionals. The company's advanced algorithms provide accurate Probability of Technical and Regulatory Success (PTRS) assessments, validated retrospectively. Intelligencia AI operates in the health tech market, focusing on pharmaceutical clients who seek to improve their drug development processes. The business model revolves around offering AI-powered solutions and data analytics services, generating revenue through subscriptions and service fees from pharmaceutical companies.

Keywords: AI-driven, drug development, pharmaceutical, clinical development, risk mitigation, data analytics, biomedical, PTRS assessments, health tech, real-time tracking.

Valuation $0–100M
Revenue $10–50M
Headcount 100–500
Total funding $10–50M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Intelligencia and the history behind them.

Talent graph

Intelligencia's talent

Book a demo to see the people
Employees mapped 113 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

4 investors on Intelligencia's cap table

Sourced from Dealroom's funding and investor records.

Series A 4 investors entered at this stage
Big Pi Ventures
MTIP
Synetro Group
ZS

Global footprint

Where Intelligencia has talent and traffic

Workforce by country
5 countries with
team presence
🇬🇷 Greece80%
🇺🇸 United States11.4%
🇬🇧 United Kingdom4.3%
🇨🇭 Switzerland2.9%
🇯🇵 Japan1.4%
5 countries shown
Web traffic by country
2.5K monthly visits
across markets
🇺🇸 United States56%
🇮🇳 India44%
Top 2 markets shown

Market sentiment

What the market is saying about Intelligencia

An AI-synthesized read of the highest-engagement posts about Intelligencia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Intelligencia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.